Pricing Log in Create free account

Cognition Therapeutics, Inc. (CGTX) vs Nordicus Partners Corporation (NORD)

Cognition Therapeutics, Inc. and Nordicus Partners Corporation are both Biotechnology companies. Cognition Therapeutics, Inc. and Nordicus Partners Corporation are of similar size ($63.2M and $60.4M). Across the 10 metrics below, Nordicus Partners Corporation leads on 7 and Cognition Therapeutics, Inc. on 3.

Valuation

Metric CGTX NORD Biotechnology median
P/E n/m n/m 10.60
P/S n/m 77.00 9.40
P/B 1.89 1.00 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 79.49 9.02
Earnings yield (24.64%) (8.70%) (32.88%)
Free cash flow yield (28.30%) (6.60%) (23.13%)

Profitability

Metric CGTX NORD Biotechnology median
Gross margin 0.00% 70.18% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (83.76%) (8.06%) (51.96%)
Return on assets (57.33%) (6.80%) (46.06%)
Return on invested capital 0.00% (4.43%) 0.00%

Growth

Metric CGTX NORD Biotechnology median
Revenue growth (TTM) — (71.68%) 6.76%
EPS growth (last fiscal year) 62.79% 30.58% 29.88%
Revenue growth, 5-year CAGR — (71.31%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CGTX NORD Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.03 0.18 4.97
Net debt to EBITDA 0.78 0.00 1.01

Dividend

Metric CGTX NORD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CGTX NORD Biotechnology median
Market cap 60.42m 63.19m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack